Skip to main content
ALYAF
OTC Technology

Alithya Reports Q3 Net Earnings Amidst Significant Goodwill Impairment and Ongoing Internal Control Weakness

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$1.169
Mkt Cap
$116.544M
52W Low
$0.95
52W High
$1.97
Market data snapshot near publication time

summarizeSummary

Alithya Group reported positive net earnings for Q3 2025, but a substantial goodwill and intangible asset impairment of $38.0 million for the nine-month period led to a significant year-to-date net loss. The company also disclosed an ongoing material weakness in its internal controls over financial reporting.


check_boxKey Events

  • Significant Goodwill and Intangible Impairment

    The company recognized a $38.0 million impairment loss on goodwill and intangibles for the nine months ended December 31, 2025, primarily affecting its Canada and Industry Solutions cash-generating units due to unachieved profitability targets.

  • Ongoing Material Weakness in Internal Controls

    Management identified an ongoing material weakness in internal control over financial reporting related to revenue processes for fixed-fee and time and material arrangements, a deficiency first reported in March 2025.

  • Mixed Revenue Performance

    Q3 2025 revenues decreased slightly by 0.5% to $115.2 million, while year-to-date revenues increased by 4.4% to $363.6 million, driven by U.S. growth (including the eVerge acquisition) but offset by a decline in Canada.

  • Year-to-Date Net Loss Worsens

    Despite Q3 2025 net earnings of $0.7 million, the significant impairment led to a year-to-date net loss of $30.1 million, a substantial increase from the $6.7 million loss in the prior year period.


auto_awesomeAnalysis

Alithya Group's latest 6-K filing reveals a mixed financial picture, with Q3 2025 net earnings of $0.7 million, a notable improvement from a loss in the prior year. However, the nine-month period was severely impacted by a $38.0 million impairment of goodwill and intangible assets, primarily in its Canada and Industry Solutions segments, indicating underperformance in these areas. This impairment, representing a substantial portion of the company's market capitalization, resulted in a significant year-to-date net loss of $30.1 million. Furthermore, the company continues to report a material weakness in its internal controls over financial reporting related to revenue processes, a critical governance concern that has been ongoing since March 2025. While adjusted EBITDA and operating cash flow showed some resilience, particularly year-to-date, the declining backlog and flat Q3 revenues, coupled with the large impairment and control issues, present a challenging outlook. The eVerge acquisition contributed to U.S. revenue growth, but overall new business momentum appears to be slowing.

At the time of this filing, ALYAF was trading at $1.17 on OTC in the Technology sector, with a market capitalization of approximately $116.5M. The 52-week trading range was $0.95 to $1.97. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ALYAF - Latest Insights

ALYAF
Feb 13, 2026, 7:16 AM EST
Filing Type: 6-K
Importance Score:
8
ALYAF
Feb 13, 2026, 7:03 AM EST
Filing Type: 6-K
Importance Score:
8